ACM
ARVN icon

Aquilo Capital Management’s Arvinas ARVN Stock Holding History

Aquilo Capital Management’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-360,766
Closed -$2.53M – 3
2025
Q1 		$2.53M Buy
360,766
+32,000
+10% +$501K 4.54% 7
2024
Q4 		$6.3M Sell
328,766
-60,000
-15% -$1.46M 9.5% 5
2024
Q3 		$9.58M Sell
388,766
-40,000
-9% -$1.04M 7.26% 6
2024
Q2 		$11.4M Buy
428,766
+23,000
+6% +$733K 11% 3
2024
Q1 		$16.8M Sell
405,766
-83,387
-17% -$3.64M 12.55% 4
2023
Q4 		$20.1M Hold
489,153
– – 12.55% 4
2023
Q3 		$9.61M Sell
489,153
-134,788
-22% -$3.31M 8.71% 7
2023
Q2 		$15.5M Sell
623,941
-5,000
-0.8% -$129K 8.58% 6
2023
Q1 		$17.2M Sell
628,941
-45,000
-7% -$1.42M 7.12% 6
2022
Q4 		$23.1M Buy
673,941
+2,196
+0.3% +$92.4K 8.66% 4
2022
Q3 		$29.9M Sell
671,745
-100,000
-13% -$4.85M 10.77% 5
2022
Q2 		$32.5M Buy
771,745
+76,498
+11% +$3.84M 11.09% 5
2022
Q1 		$46.8M Buy
695,247
+131,796
+23% +$8.98M 6.88% 5
2021
Q4 		$46.3M Buy
563,451
+208,740
+59% +$17M 5.25% 5
2021
Q3 		$29.1M Buy
+354,711
New +$31.3M 5.29% 9

Other funds holding ARVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Aquilo Capital Management's ARVN Position: Q2 2025 in Review

Aquilo Capital Management sold out of Arvinas (ARVN) in Q2 2025, closing a stake of 360,766 shares — an estimated $2.53M sold.

Aquilo Capital Management first reported a position in ARVN in Q3 2021 and held it in 15 quarters. The position peaked at $46.8M in Q1 2022. 215 funds tracked by Wall St. Rank hold ARVN as of Q2 2025.

  • Aquilo Capital Management reported no remaining Arvinas position as of Q2 2025 after selling out during the quarter.
  • Aquilo Capital Management sold 360,766 Arvinas shares in Q2 2025, an estimated $2.53M.
  • Aquilo Capital Management first reported a position in Arvinas in Q3 2021 and held it in 15 quarters.
  • Aquilo Capital Management's Arvinas position peaked at $46.8M in Q1 2022.
  • 215 funds tracked by Wall St. Rank held Arvinas as of Q2 2025.

Based on Aquilo Capital Management's 13F filing for Q2 2025.